ADHD & The Menopause
Many women notice changes in focus, memory, emotional regulation, and stress tolerance during perimenopause and menopause.
For women with ADHD, these changes can feel particularly tricky, and sometimes confusing or unsettling.
There are reasons this can feel harder, and support is available. You’re not expected to just “push through” this.
Some women find that ADHD symptoms they’ve managed for years suddenly feel harder to cope with. Others only begin to recognise ADHD traits for the first time in midlife, often after decades of coping, compensating, or being misdiagnosed with anxiety, depression, or other conditions.
This page explains what we currently understand about the relationship between ADHD and menopause and explains what might help
It may be helpful if you:
Have ADHD and feel symptoms have worsened during hormonal change
Are questioning whether you might have ADHD for the first time in midlife
Experience PMS or PMDD alongside ADHD
Find that coping strategies no longer work as they once did
Our aim is to help you understand what may be happening in your body and brain, and to feel informed about the medical and non-medical that may support you through this stage of life.
Firstly, what is the link between ADHD and the menopause?
ADHD is a neurodevelopmental condition that begins in childhood, although many women are not diagnosed until much later in life.
Women are more likely to experience the inattentive subtype of ADHD (hyperactivity that typically presents in boys), which is often overlooked earlier in life at school and in education
What’s happening with your hormones?
Perimenopause is the stage before menopause when ovarian hormone production becomes erratic.
Levels of oestrogen and progesterone fluctuate across and between cycles, before becoming consistently low after menopause.
Hormonal transitions such as perimenopause and menopause can exacerbate ADHD symptoms that were previously masked or compensated for.
For many women, this can lead to:
- Difficulties with focus, memory, and concentration (difficulty functioning)
- Increased emotional reactivity (a sense of “losing control”)
- Reduced tolerance to stress (sometimes leading to burnout)
- Sleep disruption
But why can these hormonal changes impact women with ADHD more?
Research suggests that people with ADHD have subtle differences in brain networks involved in executive function, emotional regulation, and working memory.
These networks rely heavily on neurotransmitters such as dopamine and noradrenaline. Oestradiol (a form of oestrogen) influences how these neurotransmitters function.
When oestrogen fluctuates or declines during perimenopause and menopause, executive function can become less efficient, particularly in women with ADHD. This can affect attention, motivation, emotional regulation, and stress responsiveness.
The role of progesterone
Alongside oestrogen, progesterone levels also change and decline during perimenopause. Before menopause, progesterone is produced by the ovaries and converted in the brain into a substance called allopregnanolone.
Allopregnanolone impacts on GABA, the brain’s main calming neurotransmitter, helping to reduce neural overactivity and promote a sense of calm.
For some women, including those with ADHD, progesterone can therefore be helpful, supporting sleep and reducing anxiety.
For others, it may have the opposite effect, contributing to low mood, irritability, fatigue, or reduced mental clarity.
Research suggests that women with ADHD may be particularly sensitive to changes and fluctuations in progesterone and how it affects GABA activity in the brain.
This sensitivity may help explain why progesterone feels beneficial for some women and more difficult for others, and why progesterone changes during perimenopause can contribute to emotional and cognitive symptoms.
PMS, PMDD, and lifelong hormonal sensitivity
Many younger women with ADHD notice that their symptoms worsen during the luteal phase of the menstrual cycle (the two weeks before a period).
In addition, many women with ADHD also report a long history of significant premenstrual mood symptoms, sometimes beginning in puberty.
Severe PMS and PMDD are understood to involve an increased sensitivity to normal hormonal fluctuations rather than abnormal hormone levels. This is not fully understood, but we believe it involves altered responses in GABA systems to allopregnanolone, as well as changes in serotonergic signalling — but more research is needed.
Trauma and heightened nervous system sensitivity may also be a factor for some women. For women with severe PMS or PMDD, symptoms can become more frequent, less predictable, and more severe during perimenopause.
I feel relieved to be working with someone who fully understands the complexity of PMDD, ADHD and peri menopause.”
– a Manchester Menopause Hive patient
Why can stress feel harder to manage for women with ADHD during menopause?
ADHD is associated with heightened stress reactivity and a reduced ability to return to baseline after stress.
During perimenopause and menopause, additional factors such as sleep disruption, vasomotor symptoms, and reduced hormonal buffering can increase overall nervous system load. This can make stress responses feel more intense and harder to regulate.
For some women, this may present as persistent overwhelm, irritability, emotional lability, or feeling constantly “on edge” — even in those without a previous anxiety diagnosis.
Some women with ADHD also have a history of trauma or prolonged stress, which can further influence stress physiology and nervous system responsiveness during hormonal transition.
Why is ADHD so often diagnosed in midlife?
ADHD in women has historically been under-recognised. Many girls women develop coping strategies from a young age such as perfectionism, over-preparation, people-pleasing, or anxiety-driven performance.
Perimenopause can reduce the ability to maintain these strategies due to increased cognitive load, sleep disruption, fatigue, and reduced stress tolerance.
As a result, underlying ADHD traits may become more visible for the first time in midlife.
Can HRT help?
HRT does not treat ADHD itself, but it can play an important supportive role during perimenopause and menopause.
By stabilising hormonal fluctuations and reducing symptoms such as hot flushes, poor sleep, mood changes, and brain fog, HRT may help reduce the overall impact of ADHD symptoms.
Treatment must be individualised, particularly for women with PMDD, progesterone intolerance, or hormonal sensitivity. Testosterone may also be helpful for some women.
Thinking about your lifestyle
Lifestyle strategies are more important than ever during perimenopause and menopause for women with ADHD.
Approaches that can be helpful include:
- Supporting sleep with regular routines
- Reducing or avoiding alcohol
- Staying physically active
- Eating regularly to support blood sugar
- Avoiding missed meals or long fasts
- Reducing sensory overload and screen time
- Supporting nervous system regulation
- Using systems to reduce cognitive load
- Accessing ADHD-informed coaching or therapy
Key takeaways about ADHD & the menopause
Hormonal changes during perimenopause and menopause can significantly worsen ADHD symptoms.
Many women are diagnosed with ADHD for the first time in midlife.
HRT may support functioning by reducing menopause-related symptom burden.
Individualised care is particularly important for women with ADHD and hormonal sensitivity.
Meet our Menopause Specialists, who understand both ADHD and menopause
From personalised consultations to expert guidance on perimenopause, and PMDD, they’re here to help you feel informed, supported and in control
ADHD & MENOPAUSE SUPPORT
Book an appointment with one of our ADHD & Menopause specialists
At Manchester Menopause Hive, we have experience supporting women with ADHD, neurodivergence, PMS, PMDD, and complex symptom presentations during perimenopause and menopause.
Our approach is evidence-based, individualised, and centred on listening to your experience. If this page has resonated with you, a specialist conversation can be a helpful next step.
